Impact of primary prevention and chemoprevention on the promotion of prostate cancer and the risk of developing clinically manifested prostate cancer: A prospective cohort study
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000017789
- Lead Sponsor
- The Japanese Foundation for Prostate Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 887
Inclusion Criteria
Not provided
Exclusion Criteria
1) having past or present history of prostate cancer 2) having severe complications (caridiac disease, interstitial pneumonia, bleeding tendency, uncontrollable hypertension, diabetes mellitus, etc.) 3) having uncontrolled other malignant disease (excluding carcinoma in situ, skin cancer and no evidence of recurrence more than 3 years after the treatment) 4) having any inappropriate factor judged by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in tumor marker (PSA, ratio of free to total PSA) and developing clinically manifested prostate cancer
- Secondary Outcome Measures
Name Time Method